Twitter: Trial Tuesday! Drs. RanaMcKayMD UC San Diego Health and Misha Beltran of Dana-Farber Cancer Institute co-lead A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: https://bit.ly/Alliance-A032102 #PCsm

Show Post

Scientific discovery alone is insufficient, said Small. The true mission of oncology is ensuring that knowledge is transformed into meaningful, accessible, and equitable care for all patients. (@ascocancer.bsky.social) https://cancerletter.com/the-cancer-letter/20260605_5/

Show Post

Among biology faculty at top U.S. research universities, women are now more likely than men to have Wikipedia biographies, according to a new paper. https://scim.ag/4dOuhwC

Show Post

Dr. Rana McKay UC San Diego Health leads Alliance for Clinical Trials in Oncology A031801 (RadiCaL) testing if adding the new anti-cancer drug radium-223 dichloride to the usual chemo drug cabozantinib improves outcomes for advanced renal cell cancer. Learn more at http://bit.ly/AllianceA031801

Show Post

Our AASUR Trial in High-Risk Prostate Cancer - Sean McBride - Sean McBride @seanmmcbride.bsky.social @thepcctc.bsky.social oncodaily.com/voices/sean-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Show Post